| (KOE-deen) |
| Available as generic only |
| Class: Narcotic analgesic/Antitussive |
Action Stimulates opiate receptors in the CNS; also causes respiratory depression, peripheral vasodilation, inhibition of intestinal peristalsis, stimulation of the chemoreceptors that cause vomiting, increased bladder tone and suppression of cough reflex.
Indications Relief of mild to moderate pain; cough suppression.
Contraindications Hypersensitivity to opiates; upper airway obstruction; respiratory compromise; acute asthma; diarrhea caused by poisoning or toxins.
ANALGESIC
ADULTS: IM/slow IV/PO/SC 15–60 mg q 4–6 hr (maximum 360 mg/day). CHILDREN (³ 1 YR): IM/PO/SC 0.5 mg/kg q 4–6 hr.
ANTITUSSIVE
ADULTS PO 10–20 mg q 4–6 hr (maximum 120 mg/day). CHILDREN (6–12 YR): PO 5–10 mg q 4–6 hr (maximum 60 mg/day). CHILDREN (2–6 YR): PO 2.5–5 mg q 4–6 hr (maximum 30 mg/day).
CNS depressants, (eg, tranquilizers, sedatives and alcohol): Causes additive CNS depression.
Lab Test Interferences Amylase and lipase determination: Increased levels for up to 24 hr after administration.
CV: Hypotension; orthostatic hypotension; bradycardia; tachycardia; shock. CNS: Lightheadedness; dizziness; sedation; disorientation; incoordination; euphoria; delirium. DERM: Sweating; pruritus; urticaria. EENT: Miosis. GI: Nausea; vomiting; constipation; abdominal pain; anorexia; biliary tract spasm. GU: Urinary retention or hesitancy. RESP: Laryngospasm; depression of cough reflex; respiratory depression. OTHER: Tolerance; psychological and physical dependence with chronic use.
Pregnancy: Category C. Therapeutic doses of codeine have increased duration of labor. Lactation: Excreted in breast milk. Children: Do not give IV to children < 12 yr. Children are more sensitive to effects of drug. Elderly patients: More sensitive to effects of drug. Special risk patients: Use with caution in patients with myxedema, acute alcoholism, history of drug abuse potential, acute abdominal conditions, ulcerative colitis, decreased respiratory reserve, head injury or increased intracranial pressure, hypoxia, supraventricular tachycardia, depleted blood volume, circulatory shock, hypothyroidism, and urinary/bowel elimination problems. Dependency: Codeine has abuse potential. Renal or hepatic impairment: Duration of action may be prolonged; may need to reduce dose.
| PATIENT CARE CONSIDERATIONS |
|
|
||||
Popularity: 4% [?]
RSS feed for comments on this post · TrackBack URI
Leave a reply